149 related articles for article (PubMed ID: 23851434)
1. Cardiovascular disease and risk of acute pancreatitis in a population-based study.
Bexelius TS; Ljung R; Mattsson F; Lagergren J
Pancreas; 2013 Aug; 42(6):1011-5. PubMed ID: 23851434
[TBL] [Abstract][Full Text] [Related]
2. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study.
Ljung R; Lagergren J; Bexelius TS; Mattsson F; Lindblad M
Gut; 2012 Jun; 61(6):873-6. PubMed ID: 21957155
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden.
Bexelius TS; Ljung R; Mattsson F; Lu Y; Lindblad M
BMC Gastroenterol; 2017 Mar; 17(1):36. PubMed ID: 28270103
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and risk of acute pancreatitis.
Razavi D; Lindblad M; Bexelius T; Oskarsson V; Sadr-Azodi O; Ljung R
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1337-1341. PubMed ID: 27651204
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
[TBL] [Abstract][Full Text] [Related]
7. Acid-suppressing drugs and gastroesophageal reflux disease as risk factors for acute pancreatitis--results from a Swedish Case-Control Study.
Sundström A; Blomgren K; Alfredsson L; Wiholm BE
Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):141-9. PubMed ID: 16200654
[TBL] [Abstract][Full Text] [Related]
8. A Swedish case-control network for studies of drug-induced morbidity--acute pancreatitis.
Blomgren KB; Sundström A; Steineck G; Genell S; Sjöstedt S; Wiholm BE
Eur J Clin Pharmacol; 2002 Jul; 58(4):275-83. PubMed ID: 12136374
[TBL] [Abstract][Full Text] [Related]
9. Risk of pancreatitis in 14,000 individuals with celiac disease.
Ludvigsson JF; Montgomery SM; Ekbom A
Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1347-53. PubMed ID: 17702659
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors and the risk of acute pancreatitis: a Swedish population-based case-control study.
Ljung R; Rück C; Mattsson F; Bexelius TS; Lagergren J; Lindblad M
J Clin Psychopharmacol; 2012 Jun; 32(3):336-40. PubMed ID: 22544014
[TBL] [Abstract][Full Text] [Related]
11. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study.
Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP
Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of severe acute pancreatitis in patients with diabetes.
Shen HN; Chang YH; Chen HF; Lu CL; Li CY
Diabet Med; 2012 Nov; 29(11):1419-24. PubMed ID: 22506974
[TBL] [Abstract][Full Text] [Related]
13. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
Floyd A; Pedersen L; Nielsen GL; Thorlacius-Ussing O; Sorensen HT
Am J Gastroenterol; 2003 Jun; 98(6):1305-8. PubMed ID: 12818274
[TBL] [Abstract][Full Text] [Related]
14. Statins and the risk of acute pancreatitis: a population-based case-control study.
Thisted H; Jacobsen J; Munk EM; Nørgaard B; Friis S; McLaughlin JK; Sørensen HT; Johnsen SP
Aliment Pharmacol Ther; 2006 Jan; 23(1):185-90. PubMed ID: 16393296
[TBL] [Abstract][Full Text] [Related]
15. Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan.
Hung SC; Hung SR; Lin CL; Lai SW; Hung HC
Am J Gastroenterol; 2015 Oct; 110(10):1490-6. PubMed ID: 26323189
[TBL] [Abstract][Full Text] [Related]
16. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
17. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
19. Finasteride use and acute pancreatitis in Taiwan.
Lai SW; Lai HC; Lin CL; Liao KF
J Clin Pharmacol; 2015 Jun; 55(6):657-60. PubMed ID: 25573785
[TBL] [Abstract][Full Text] [Related]
20. Digoxin use may increase the relative risk of acute pancreatitis: A population-based case-control study in Taiwan.
Lai SW; Lin CL; Liao KF
Int J Cardiol; 2015 Feb; 181():235-8. PubMed ID: 25528527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
